CLINICAL_TRIALS
trial_result
· 2021-11-22
Clinical Trial Update: Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease [Phase 3]
Summary
Phase 3 clinical trial update for OC-01 nasal spray in dry eye disease, reporting results upon completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oyster Point Pharma, Inc. | Conditions: Dry Eye Disease (DED) | Phase 3 | Status: COMPLETED | Results posted: 2021-11-22